Guardian Partners »

Sarepta Therapeutics shares owned by Guardian Partners

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Guardian Partners from 13F filings

Historical chart of Guardian Partners investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Guardian Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Guardian Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $377 21 17.95

More positions owned by Guardian Partners

Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Cibc Cad (CM)
Enbridge (ENB)
Canadian Natl Ry (CNI)
JPMorgan Chase & Co. (JPM)
Apple (AAPL)
Microsoft Corporation (MSFT)
Johnson & Johnson (JNJ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Alphabet Cap Stk Cl A (GOOGL)
Ing Groep Sponsored Adr (ING)

View all positions for Guardian Partners

Top funds holding Sarepta Therapeutics

BlackRock
Vanguard Portfolio Management
State Street Corporation
Two Sigma Investments
Vanguard Capital Management
First Trust Advisors
AQR Capital Management
Geode Capital Management
Morgan Stanley
Erste Asset Management GmbH
Marshall Wace
Standard Life Aberdeen
Bank of America Corporation
Goldman Sachs Group
Susquehanna International

View all funds holding Sarepta Therapeutics